But at this point 5% is only like 8 cents, so at least there's that? And from a technical perspective, the good news is that I see firm support at $0.00. Lol
You must have corrected while I was typing...someone in the office gave you a hint? Or just in a hurry to say I was wrong?
You have to smarten up on your reading and understanding capability....From the 2Q earning Highlights.
"Reported record quarterly revenues of $14.4 million including 3.3 million in OTREXUP™ sales and
$ 1.8 million in revenues generated from epinephrine auto injector devices sold and shipped to Teva
during the second quarter."
AGAIN AGAIN READ CAREFULLY
"and $ 1.8 million in revenues generated from epinephrine auto injector devices sold and shipped to Teva during the second quarter."
I wonder who the less intelligent individuals are, that gave you 2 greenies for posting totally erroneous information.
You did not do it on purpose did you?
I stand corrected.
ATRS said they sold $1.8MM (dollars) of Epi injectors, so the other $3MM might have been licensing .
My mistake and I still don't know how much they getting per injector
Just bought more of this turd knocker... I'm a glutton for punishment... This has to be the worst stock with the worst management of all-time. 800 more shares to add to the rubbish pile.
Yep, I didn't type that right. Basically I mean we aren't going to really get meaningful money until royalties come in on sales of epi. No positive earnings until epi, period.
ATRS said they sold 1.8MM injectors, not $1.8MM total.
Based on 10Q they got about $2.75 per injector.
So if they can sell about 4MM injectors this Q, it will be same as the $5MM from LEO
The injector sales are great, but they aren't going to support this stock at its current valuation. Approval and actual sales with royalties are the only things that will move the needle.
The question is will ATRS show a profit in Q3 given the apparent ramp-up in injector sales to TEVA as well as increasing sales of Otrexup. I don't think we will because we need to replace the $5 million in one-time revenue from Q2 and then some.
2015 2014 2015 2014
$ 4,796,402 $ 1,856,526 $ 7,129,217 $ 4,304,813
5,142,857 857,143 6,000,000 1,714,286
1,435,196 603,431 3,334,901 656,835
1,393,527 587,520 2,268,672 659,807
828,651 1,744,912 2,300,067 2,830,008
The injectors are just sold to TEVA on a price per piece basis with an associated margin on each device. Nothing more Nothing less. In Q2 they billed or booked 1,8MM in injector sales to TEVA.
Baloney. First you tell us about your hard drive about to crash, tell us about little things going on, big things going on in politics but you don't bother to tell us your taking a break before taking a break then show up with a new ID. You and davis disappear on the same date and your investment philosophy according to your ihub profile is, making fools of other posters and that was a perfect persona of your davis ID.
Investment Philosophy Buy low, greed kills.
Occupation Making fools of other posters
Interests/Hobby Golf, stocks, chasing skirts
Favorite Quote "The fastest way to make a small fortune from investing in Bio-tech is to start out with a large fortune."
You're not making a fool out of me